ASTARABINE Trademark
Serial Number: 79178730 • Registration: 4971204
ASTARABINE is a trademark filed by
BioSight Ltd.
on October 14, 2015. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Webb & Co., Patent Attorneys
3 Pekeris Street,
P.O. Box 2189
76121 Rehovot,
ISRAEL
Trademark Details
Filing Date
October 14, 2015
Registration Date
June 7, 2016
Published for Opposition
March 22, 2016
Cancellation Date
October 15, 2025
Goods & Services
Pharmaceutical preparations for the treatment of cancer
Filing History
DEATH OF INTERNATIONAL REGISTRATION
May 7, 2026 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Oct 3, 2023 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 14, 2023 INTS
INVALIDATION PROCESSED
Sep 13, 2023 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 23, 2023 INTR
CANCELLED SECTION 71
Dec 23, 2022 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Oct 25, 2019 NREP
NOTIFICATION PROCESSED BY IB
Dec 9, 2016 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jul 8, 2016 FICS
FINAL DISPOSITION PROCESSED
Jul 8, 2016 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 7, 2016 GPAR
REGISTERED-PRINCIPAL REGISTER
Jun 7, 2016 R.PR
PUBLISHED FOR OPPOSITION
Mar 22, 2016 PUBO
NOTIFICATION PROCESSED BY IB
Mar 18, 2016 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 2, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 2, 2016 OP2R
NOTICE OF PUBLICATION
Mar 2, 2016 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2016 CNSA
ASSIGNED TO EXAMINER
Feb 4, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 29, 2015 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 17, 2015 REPR
